Sruli refers to Sruli monoclonal antibody injection, now the seventh domestic approved listing specifications 100ml a bottle of the price of about 5588 yuan, different regions, different pharmacies prices will fluctuate slightly, the specific price is recommended to consult the local hospitals and pharmacies. Srolizumab injection belongs to the PD-1 inhibitor, is a class of drugs independently developed in China. It is mainly applied to the treatment of unresectable and refractory Hodgkin’s lymphoma and small cell lung cancer. In addition, Srolizumab Injection may cause adverse reactions such as nausea, vomiting, diarrhea, etc. The use of this product should be prohibited for patients with severe impairment of liver and kidney function. Srolizumab injection needs to be used under the guidance of a doctor, follow the doctor’s instructions, reasonable use of medication.